May 15 (Reuters) - TriSalus Life Sciences Inc TLSI.O:
TRISALUS LIFE SCIENCES Q1 PRETAX PROFIT USD -10.37 MILLION
TRISALUS LIFE SCIENCES Q1 REVENUE USD 9.167 MILLION VERSUS. IBES ESTIMATE USD 9.04 MILLION
TRISALUS LIFE SCIENCES Q1 BASIC EPS USD -0.39 VERSUS. IBES ESTIMATE USD -0.22
TRISALUS LIFE SCIENCES Q1 INCOME FROM OPERATIONS USD -7.329 MILLION
TRISALUS LIFE SCIENCES Q1 GROSS PROFIT USD 7.672 MILLION
Source text: ID:nBwdRqzSa
Further company coverage: TLSI.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.